Clinical trial
Effects of Motor Control Exercises and Myofascial Release Technique on Muscle Strength, Pain Threshold, and Muscle Activation Pattern in Greater Trochanteric Pain Syndrome
NCT07936604 is registered in ClinicalTrials.gov with Harran University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Motor Control Exercises and Myofascial Release Technique on Muscle Strength, Pain Threshold, and Muscle Activation Pattern in Greater Trochanteric Pain Syndrome
- Lead sponsor
- Harran University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 30, 2026
- Completion date
- December 31, 2026
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
greater trochanteric pain syndrome
Arms
As registered; 3 arms.
-
Motor Control Exercise + Myofascial Release
Participants will receive a motor control exercise program combined with myofascial release techniques for 8 weeks.
-
Motor Control Exercise
Participants will receive a motor control exercise program for 8 weeks.
-
Home Exercise Program
Participants will receive a home-based motor control exercise program in brochure format for 8 weeks.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Short-Form McGill Pain Questionnaire -Pain Rating Index
Pain characteristics and severity will be assessed using the 15-item Pain Rating Index of the Short-Form McGill Pain Questionnaire (SF-MPQ). Each item is scored from 0 (none) to 3 (severe), resulting in a total score ranging from 0 to 45. Higher scores indicate greater pain severity and a worse outcome.
-
Short-Form McGill Pain Questionnaire - Present Pain Intensity
Current pain intensity will be assessed using the Present Pain Intensity (PPI) component of the Short-Form McGill Pain Questionnaire (SF-MPQ). Scores range from 0 (no pain) to 5 (excruciating pain), with higher scores indicating greater current pain intensity and a worse outcome.
-
Short-Form McGill Pain Questionnaire - Visual Analog Scale
Pain intensity will be assessed using the Visual Analog Scale (VAS) included in the Short-Form McGill Pain Questionnaire (SF-MPQ). The scale ranges from 0 to 10 mm, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and a worse outcome.
Lead sponsor's other trials
Harran University, most recent start first.
+58 more trials See the organization page